A 65,000-dalton (65K) antigen found in Raji cells by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis has been identified as an Epstein-Barr virus nuclear antigen (EBNA). This identification is based on the following evidence. The 65K antigen is detected in Raji cells but not in three Epstein-Barr virus (-) (8, 9, 11, 25) . These antigens are membrane antigen, virus capsid antigen, early antigen, and nuclear antigen (EBNA). Immunoprecipitation experiments performed in several laboratories have demonstrated that membrane, virus caspid, and early antigen each consist of more than one protein (3, 5, 10, 17, 18, 20, 23, 28, 30) . Recently, a 48,000-dalton (48K) protein has been identified as an EBNA on the basis of immunoprecipitation experiments and biochemical purification of the antigen (14, 15). Identification of EBNA by classical radioimmunoprecipitation techniques has been difficult for three reasons. First, EBNA constitutes less than one-thousandth of the total cellular protein. Second, the in vivo radiolabeling of constitutive intracellular proteins yields proteins of relatively low specific activity. Third, human sera which effectively precipitate EBNA are rare in our experience. Therefore, to identify EBNA we turned to the techniques of radioimmunoelectrophoresis (RIE) and fluoroimmunoelectrophoresis (FIE). Using these techniques, we have identified a second EBNA with a molecular weight of 65K in Raji cells. Antigens with similar molecular weights were also detected in B95-8, P3HR-1, and Namalwa cells.
Four Epstein-Barr virus (EBV) antigens have been defined on the basis of the staining patterns observed in various immunoflourescence assays (8, 9, 11, 25) . These antigens are membrane antigen, virus capsid antigen, early antigen, and nuclear antigen (EBNA). Immunoprecipitation experiments performed in several laboratories have demonstrated that membrane, virus caspid, and early antigen each consist of more than one protein (3, 5, 10, 17, 18, 20, 23, 28, 30) . Recently, a 48,000-dalton (48K) protein has been identified as an EBNA on the basis of immunoprecipitation experiments and biochemical purification of the antigen (14, 15) . Identification of EBNA by classical radioimmunoprecipitation techniques has been difficult for three reasons. First, EBNA constitutes less than one-thousandth of the total cellular protein. Second, the in vivo radiolabeling of constitutive intracellular proteins yields proteins of relatively low specific activity. Third, human sera which effectively precipitate EBNA are rare in our experience. Therefore, to identify EBNA we turned to the techniques of radioimmunoelectrophoresis (RIE) and fluoroimmunoelectrophoresis (FIE) . Using these techniques, we have identified a second EBNA with a molecular weight of 65K in Raji cells. Antigens with similar molecular weights were also detected in B95-8, P3HR-1, and Namalwa cells.
MATERIALS AND METHODS
Cell lines and growth conditions. All B lymphocyte cell lines were grown in RPMI 1640 medium containing 10% decomplemented fetal bovine serum supplemented with 2 mM L-glutamine, penicillin (50 U/ml), and streptomycin (50 J,g/ml). The cells were grown at 37°C in an atmosphere of 95% air, 5% Co2. B95-8 cells, an EBV producer line, were grown in the above medium supplemented with 100 t&g of phosphonoacetic acid (Richmond Organics) per ml to block late viral protein synthesis (29) . However, the B95-8 cells were 2 to 3% early antigen (+) at the time of harvest. P3HR-1 (N) is an EBV-positive nonproducer subline of P3HR-1 obtained from Berge Hampar and was negative for all EBV antigens except EBNA. P3HR-1 (P) is an EBV producer line obtained from Meihan Nonoyama. BJAB and Ramos are EBV-negative B cell lines. B1-19 is an EBV-positive converted BJAB line obtained from Harald zur Hausen (7) , and B1-19-2 is an EBNA-negative subline of B1-19 cloned in our laboratory. Both P3HR-1 (P) and B1-19 were passaged at daily intervals before harvest to minimize the number of early antigen (+) virus capsid antigen (+) cells. The Raji and Namalwa cell lines are EBVpositive, nonproducer cell lines.
Description of human sera. Sera 1 and 12 were from individuals who were negative for antibodies to all EBV antigens. Sera 6 purchased from GIBCO and had EBNA antibody titers of 1/40 and 1/80, respectively. All of the sera were negative for nonspecific antinuclear antibody when tested on Ramos and BJAB cells by ACIF. Preparation of whole cell SDS lysates. A total of 1 x 108 cells were washed three times in phosphatebuffered saline (PBS) and suspended in 0.8 ml of water. The cells were lysed by the addition of 0.1 ml of 10% sodium dodecyl sulfate (SDS), and the DNA was sheared by passage through a 27G needle. The protein content of the lysates was determined by the method of Lowry et al. (13) , and the lysates were stored at -70°C before use. lodination of proteins. Protein A (Pharmacia Fine Chemicals, Inc.) and human immunoglobulin IgM and IgG (Cappel Laboratories) were iodinated by the following procedure. Twenty-five microliters of protein solution at 1 mg/ml of 0.4 M Tris-hydrochloride-4 mM EDTA (pH 7.4) (RB) were mixed with an additional 25 pl of RB. Ten microliters containing 1 mCi of Na'25I (New England Nuclear Corp.; carrierfree in 0.1 M NaOH) was added, followed by 10 td of chloramine T at 2.5 mg/ml of RB. After a 60-s shaking at room temperature, the reaction was terminated by the addition of 25 p1 of sodium metabisulfite at 2.5 mg/ ml of RB. The reaction mixture was chromatographed on a 10-ml G-25 Sephadex column, poured in a 10-ml disposable pipette, and equilibrated with PBS-1% bovine serum albumin. Fractions (0.5 ml) were collected, and the fractions in the leading portion of the excluded peak were pooled. Specific activities of 1 x 107 to 2 x 107 cpm/,ug were routinely obtained.
RIE. RIE was performed by a modified procedure of Adair et al. (1) . Whole cell SDS lysates and '25I-labeled human IgM and IgG standards were disassociated in 1.4% SDS-0.5 M f)-mercaptoethanol at 80°C for 10 min. The samples were electrophoresed in the discontinuous gel system described by Laemmli (12) . The gel consisted of a 3% acrylamide-0.08% bisacrylamide stacking gel (1.5 cm long) and an 8% acrylamide-0.2% bisacrylamide running gel (8.5 cm long). Both gels and the electrode buffer contained 0.1% SDS. After electrophoresis the SDS was eluted from the gel by washing in 3 1-liter volumes of PBS, followed by 2 1-liter volumes of PBS, containing 1% bovine serum albumin and 0.02% NaN3. Each of these washes lasted 0.5 h. Then gel was covered with human sera diluted 1:2 in PBS-1% bovine serum albumin-0.02% NaN3 and incubated at 37°C in a humid atmosphere for 1 h. After incubation, the gel was washed with 6 250-ml volumes of PBS-0.02% NaN3 for a total of 1.5 Procedure for FIE. Whole cell SDS lysates and FITC-conjugated IgM and IgG standards were disassociated and electrophoresed as previously described (27) . The immunofluorescence assay for antigen bands was performed by a modified procedure of Towbin et al. (31) . After electrophoresis, the gel slab was washed three times (0.5 h/wash) in 500 ml of 0.025 M Tris-0.192 M glycine-20% methanol (pH 8.5) (TGM) to remove SDS. The following multilayered transfer assembly was put together in a tray of TGM buffer so that bubbles were not introduced between the filter paper and the gel. A rectangular metal anode (13 by 20 cm) was placed in the bottom of the tray, followed by a Scotch Brite pad, a piece of Whatman 3MM paper, a sheet of HAWP filter paper (Millipore Corp.), the acrylamide gel slab, another piece of 3MM paper, another Scotch Brite pad, and finally a rectangular metal cathode. The layers were held together with nylon clamps. The assembly was placed in a tank of TGM buffer with the electrodes in a vertical position so that bubbles formed during transfer would escape upward. Electrophoretic transfer was carried out toward the anode at 6 V for 4.5 h with the electrodes 1.5 cm apart. Control experiments performed with 3H-amino acid-labeled SDS cell lysates indicated that 80% of the extract protein was removed from the gel by this procedure and about 65% of the electro-eluted proteins were bound to the HAWP paper. The overall efficiency of transfer was therefore about 50%. After transfer, the HAWP filter paper was stored overnight in PBS at 5°C. Residual binding sites on the paper were blocked by incubation for 2 h at 37°C in decomplemented calf serum diluted 1:2 in PBS. Then the calf serum was removed, and the paper was covered with human serum diluted 1:2 in decomplemented calf serum and incubated at 37°C for 1 h. After washing six times with 100 ml of PBS (10 min/wash), the paper was covered with FITC-conjugated goat antihuman IgG, heavy and light chain specific (Hyland Diagnostics; 5 Biochemical fractionation of EBNA by DNASepharose and Blue Dextran-Sepharose chromatography. Chromatographic separation of EBNA on a DNA-Sepharose column was performed as previously described (19) . The fractions which eluted from the DNA affinity column with 0.5 M NaCl contained all of the measurable CF activity and all of the activity in the acid-fixed nuclear binding assay (21) . The 0.5 M NaCl eluate was diluted to 0.15 M NaCl by the addition of buffer A-10% glycerol without NaCl. The diluted eluate was passed through a Blue Dextran-Sepharose column (2.4 by 0.9 cm; 8.6 mg of Blue Dextran bound per ml of packed Sepharose) prepared as described by Ryan and Vestling (26) and equilibrated in buffer A-10% glycerol. The column was eluted in succession with 6-ml volumes of buffer A-10% glycerol containing 0.5, 1.0, or 2.0 M NaCl. Samples of all of the column fractions were dialyzed first against Veronal buffer for the determination of protein and CF activity and then against 0.02% SDS for FIE.
Absorption of EBNA antibody. Partial purification of EBNA for absorption experiments was achieved by DNA-Sepharose chromatography of Raji cell extracts performed as described above, followed by dialysis against 0.02% SDS and electrophoretic separation of the proteins in the 0.5 M NaCl eluate on an 8% SDS-acrylamide gel slab (12, 27 man IgG probe. Pooled human serum 9 ( Fig. 2A) gave an antigen pattern which was identical to the RIE pattern obtained with this serum. Antigens were detected at 72, 70, and 65K in B95-8/PAA, P3HR-1, and Raji cells, respectively. Pooled human serum 10 gave a pattern similar to serum 9, except that a faint additional antigen band was detected in B95-8/PAA and Raji at 81K (data not shown). Figure 2B and C show the FIE results with two individual EBNA (+) sera, 6 and 11. Serum 6 (Fig. 2B ) detected antigens at 81, 72, 51, 48, 44, and 39K in B95-8/PAA, at 70K in P3HR-1, and at 81 and 65K in Raji. Serum 11 (Fig. 2C ) detected antigens at 81 and 72K in B95-8/PAA and at 70 and 65K in P3HR-1 (N) and Raji, respectively. An EBNA (-) serum did not detect antigens in these lysates by FIE.
The results obtained by RIE and FIE on whole cell lysates can be summarized as follows. All four EBNA (+) sera tested detected antigens between 65 and 72K in Raji, P3HR-1, and B95-8/PAA cells. Three of these sera detected a second fainter antigen band at 81K in B95-8/ PAA cells, and two of these sera detected a similar antigen in Raji cells. A single serum detected four additional antigen bands between 39 and 51K in B95-8/PAA cells. Antigens were not detected in three EBNA (-) cell lines, and they were not detected with EBNA (-) sera. In all experiments, numerous faint bands were seen which were of equal intensity in both the tracks containing the EBNA (-) and those containing the EBNA (+) cell extracts. These represent background nonspecific binding of the FITC an-
. antigen since the cells were 2 to 3% positive for ;ently associated early antigen. However, FIE on the EBNA (+), vere the antigens nonproducer cell line, Namalwa (Fig. 3B , track en 65 and 72K, C) indicates that an antigen of similar molecular formed cell line weight (i.e., 73K) was detected in these early molecular weight antigen (-) cells. f the four EBNA Biochemical characterization of the 65K i cells or both. It antigen detected in Raji cells by FIE. The gens detected by antigens detected between 65 and 73K by FIE l associated with were strongly associated with EBNA since an 7 detected with a antigen in this weight range was found in all four Icells. EBNA (+) cell lines tested. Accordingly, we 'NA and the 70K decided to examine the biochemical properties cells was further of the antigen. In these studies, we focused our e Bl-19 cell line. attention on the 65K antigen found in Raji cells, )ned in the labo-since EBNA can readily be detected in Raji cell rom a culture of extracts by a microcomplement fixation assay -1 virus (7). Most without interference from other viral antigens ure were EBNA (16) . and B1-19-2 was Whole cell, nuclear, and cytoplasmic lysates from the B1-19 were prepared from Raji cells. The lysates were Figure 3A shows first assayed for the EBNA-associated CF antiat in P3HR-1 (P), gen and then tested by FIE. The specific activisent from BJAB. ties (C50 U/mg of protein) of the whole cell, n the EBNA (+) nuclear, and cytoplasmic lysates were 118, 185, [-infected BJAB, and 40, respectively. The FIE results in the antigen (2, 16) . Accordingly, we prepared a crude Raji cell sonic extract and chromatographed it on DNA-Sepharose and Blue Dextran-Sepharose affinity columns. As Table 1 indicates, all of the measurable CF activity eluted from DNA-Sepharose, with 0.5 M NaCl giving a sevenfold purification of the antigen. The 0.5 M NaCl eluate was chromatographed on a Blue Dextran-Sepharose column, and all of the recoverable CF activity eluted with 2 M NaCl for a total purification of 46-fold. Samples of each column eluate were concentrated, and the same amount of protein from each eluate was assayed for the 65 and 81K antigens by FIE. Since the same amount of protein was electrophoresed in each track, the intensity of the antigen band should correspond to the relative concentration of antigen in a particular fraction. Figure 5 indicates that both the 65 and 81K antigens were found in the 0.5 M NaCl eluate from DNASepharose (track D). However, the 65K antigen was the predominant antigen found in the 2 M NaCl eluate from Blue Dextran-Sepharose (track I). Furthermore, the intensity of the 65K antigen band increased at each step of EBNA purification as measured by CF, as would be expected if both the CF and FIE assays measured the same antigen. Since less than 0.5% of the initial sonically treated cell protein was found in the 2 M NaCl eluate from Blue Dextran-Sepharose, the probability of this association being fortuitious is extremely remote. In contrast, the 81K antigen elutes from the Blue Dextran column over the entire range of salt concentrations employed. Several other faint antigen bands were observed in the 2 M NaCl Blue Dextran eluate. These antigens had molecular weights less than 65K and the pattern of decreasing intensity with decreasing molecular weight which they exhibited suggests that they represent processed or degraded products of the 65K antigen.
Absorption of EBNA antibody by the 65K Raji antigen. Partial DISCUSSION It has been postulated that EBNA plays an important role in the initiation or maintenance of B lymphocyte transformation. This hypothesis was based on the fact that EBNA is the first EBV antigen found during the primary infection of lymphocytes and on the fact that it is the only antigen expressed in all EBV-transformed cell lines (6) . In this paper, we present evidence that a 65K antigen is an EBNA. The evidence is summarized as follows. First, the 65K antigen is detected in Raji cells by RIE and FIE, but not in three EBV (-) human B cell lines. Second, the 65K antigen is found preferentially in the nucleus. Third, the antigen coelutes with EBNA during partial purification by DNA-Sepharose and Blue Dextran-Sepharose chromatography. Fourth, the partially purified 65K antigen is an effective absorbant of EBNA antibody as measured by the ACIF assay. In addition, antigens were detected by the same EBV (+) sera at 70K in both producer and nonproducer sublines of P3HR-1 cells, and at 72 and 73K in B95-8 and Namalwa cells, respectively. These antigens are probably the homologs of the 65K antigen detected in Raji. This hypothesis is supported for (15) . This difference in molecular weight cannot be attributed to the use of different molecular weight standards because the 48K antigen clearly has a mobility faster than the -y chain of IgG (15) , whereas the 65K antigen has a mobility substantially less than the -y chain. It is possible that the two antigens have related primary amino acid sequences, the 48K EBNA being a processed or degraded product of the 65K EBNA. Alternatively, it is possible that the two antigens are distinct. There are at least two reasons why we may not have detected the 48K antigen by RIE and FIE. First, since the treatment of Raji extracts with SDS and fi-mercaptoethanol inactivates some of the EBNA activity detected by complement fixation, it is possible that the antigenicity of some EBNA components is completely destroyed under the electrophoretic conditions used in the RIE and FIE assays. Second, the 48K EBNA identified by Luka et al. (15) was detected with sera from Burkitt's lymphoma patients with titers of 1/640 in the ACIF assay. None of the sera available to us in sufficient quantities has titers this high.
The hypothesis that EBNA consists of multiple antigenic determinants is supported by studies involving comparative titration of human sera on the nuclear antigens of EBV and the EBV-like viruses of gorillas and baboons. The results indicate that EBNA has at least two determinants, one unique to EBNA and another shared by human, gorilla, and baboon viral nuclear antigens (24) . The hypothesis of multiple EBNA determinants is also supported by the results of reciprocal absorption experiments performed in our laboratory. Absorption of certain sera with fixed P3HR-1 or Raji cells completely removed all antibody detected in homologous ACIF reactions but not in heterologous ACIF reactions. These experiments indicate that EBNA consists of multiple antigenic determinants located on either the same of different molecules. The existence of multiple EBNAs is consistent with the hybridization data of Powell et al. (22) . In this study, it was shown that Raji and Namalwa contain sufficient polyadenlyated EBV-specific RNA to code for as many as four EBV proteins. It is interesting to consider the 81K antigen in this light. The 81K antigen was detected in Raji or B95-8 or both with three of the four EBV (+) sera tested. This antigen also binds to DNA-Sepharose columns. However, its chromatographic properties on Blue Dextran columns clearly distinguish it from the 65K antigen. Recent data indicate that the 81K antigen, like the 65K antigen, is found predominantly in the nucleus. Therefore, it is possible that the 81K antigen is a third EBV nuclear antigen. To date, all of the sera tested, which react with the 81K antigen, detect only a faint, slightly diffuse band. The study of this antigen would be facilitated by the identification of a serum which reacted strongly with it by FIE. Four additional antigens with molecular weights between 39 and 51K were detected by FIE. However, it is unlikely that these antigens represent EBNA since they were detected with only one out of four sera tested, and in only one (i.e., B95-8/PAA) of the three EBNA (+) lines tested.
EBNA can be purified 700-to 800-fold by a sequence of DNA-Sepharose, Blue DextranSepharose, and hydroxylapatite chromatography (15) . Nevertheless, in our experience, the EBNA-containing fraction from the hydroxylapatite column still contains about 20 protein bands. Additional purification of EBNA for biological studies would be facilitated by immunoaffinity chromatography if an extremely high titered monospecific serum was available in sufficient quantity. In principle, partially purified EBNA can be used to immunize mice for the selection of monoclonal antibodies if the appropriate techniques can be developed for screening large numbers of hybridomas. This work is in progress in our laboratory.
